Company intelligence / Profile preview

BioCide Labs

Melbourne, Florida, United States

Ownership: Private
Development stage: Other

Overview

BioCide Labs is a healthcare and environmental safety company specializing in the development of advanced antimicrobial and mold remediation products. The company offers a range of EPA-registered disinfectants, most notably BioCide 100, which is formulated to eliminate mold, bacteria, and viruses on various surfaces. Their product portfolio serves both professional remediation contractors and residential consumers, providing tools for testing, cleaning, and preventing microbial growth. BioCide Labs focuses on delivering effective solutions for maintaining healthy indoor air quality and ensuring sterile environments in commercial and residential settings.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeDisinfectant
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on BioCide Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioCide Labs.

Explore the full profile